Reply

Authors

  • Chiun Hsu M.D., Ph.D.,

    1. Departments of Oncology, Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
    2. Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan
    Search for more papers by this author
  • Pei-Jer Chen M.D., Ph.D.,

    1. Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
    2. Hepatitis Research Center, National Taiwan University College of Medicine, Taipei, Taiwan
    Search for more papers by this author
  • Ann-Lii Cheng M.D., Ph.D.

    1. Departments of Oncology, Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
    2. Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan
    Search for more papers by this author

  • Potential conflict of interest: Dr. Chen consults for, advises, and is on the speakers' bureau for Bristol-Myers Squibb, Roche, and Gilead.

No abstract is available for this article.

Ancillary